World Market for Psychotherapeutic Drugs Could Reach $50 Billion in Sales by 2010, Says New Report Available from Piribo.com

Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has just added a report on the potential market for Psychotherapeutic Drugs to its collection. “The World Market for Psychotherapeutic Drugs” forecasts a potential $50 billion market by 2010, growing from $35.7 billion in 2005.

The Psychotherapeutic drugs market has huge potential. The steadily increasing success of current drugs on the market as well as the potential success of numerous drugs currently in late stage development or awaiting regulatory approval, mean that sales of psychotherapeutic drugs treating everything from schizophrenia and depression to ADHD and anxiety are expected to increase.

According to this report, antipsychotics and antimanics along with antidepressants make up the greatest share of worldwide sales, accounting for nearly 80% of the market. Sales of antianxiety drugs, ADHD stimulants and nonstimulants, and other psychotherapeutic drugs segments add to the mix of remedies to treat a remarkably under-treated global incidence of mental illness.

There is the potential for new markets to open up as negativity and stigma surrounding mental health issues continue to be broken down. Currently the U.S. accounts for more than 62% of worldwide sales. In contrast, Japan accounts for only 2% of global sales.

This exhaustive guide, to this booming market, gives an historical market overview, including condition statistics and market forecasts for each of the major psychotherapeutic segments. It also includes in-depth company profiles of emerging competitors and leaders in the field, and profiles of drugs in the pipeline with expected approval status and implications for their impact on the market. It anticipates new products bringing in an additional $6.3 billion by 2010 increasing the competitive outlook in many segments.

“The World Market for Psychotherapeutic Drugs,” is available in PDF format from Piribo. For more information go to: http://www.piribo.com/publications/therapeutic/cns_neurology/world_market_psychotherapeutic_drugs.html


About Piribo.
Piribo (http:www.piribo.com) is a UK-based independent online store supplying business information on the pharmaceutical and biotechnology industries. The website now carries over 6,000 English language titles including, market reports, studies and books and is the UK’s largest online biopharma information store. Subscribers receive a free monthly newsletter and email alerts on new titles in their areas of interest. The company was established in 2004.